Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Aptamers Market – Insights

Aptamers are short single-stranded DNA or RNA (ssDNA or ssRNA) molecules that bind to a specific target protein, lipid, or nucleic acid molecules with high specificity. Aptamers can also be conjugated to drugs, and work as drug-delivery systems. For example, aptamers have been conjugated with chemotherapy drugs to turn target and bind to only cancerous cells and leave healthy tissue untouched.

Furthermore, factors such as lesser possibility of provoking undesired immune responses, high thermal stability, and cost-efficiency provide are expected to boost demand for aptamers. These are produced through a technique called Systematic Evolution of Ligands by Exponential enrichment (SELEX), which is time-consuming and involves iterative steps. Thus, to overcome this disadvantage, Vivonics Inc. developed and patented a one-step rapid technique named Rapid Isolation of DNA Aptamers (RIDA) for the isolation of high affinity and high selectivity aptamers. Such factors are expected to fuel adoption of aptamers.

Aptamers have attracted much attention recently for potential therapeutic and diagnostic purposes and have gained worldwide preference over antibodies owing to the former’s key benefits – lower cost, ability to not destroy neighboring cells, greater binding affinity, longer shelf life and, high specificity. The wide range of applications of aptamers has dominate medical industry to convey monetary clinical evidence and allow companies to significantly increase their influence to capture the untapped potential of aptamers, functioning as a key development opportunity that will propel the market growth.

The global aptamers market size was valued at US$ 3,626.13 million in 2019, and is expected to witness a CAGR of 18.5% over the forecast period (2019 – 2027).

Global Aptamers Market Share (%) Analysis, By Type, 2019

Aptamers  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

An increasing number of applications is expected to drive the market growth

Aptamer products can be used as biosensors, diagnostics research agents or can be considered as a tool for biomarker or drug discovery. It can also be used for targeted therapeutics and bio-industrial applications. In-vivo aptamers can avoid majority of bench testing, save time, and around 35% of the R&D cost. It permits the natural selection of drug candidates in whole animal models, which reduces the false starts and requires fewer animals for drug evaluation. All these factors have led a large number of companies to invest in this market.

Moreover, growing incidence of life-threatening diseases such as cancer has directed many companies to introduce new detection assays based on aptamers therapy which is expected to help drive the growth of the aptamers market. In March 2017, Aptamer Sciences, Inc. unveiled the multi-protein biomarker assay by using this technology for detection of lung cancer.

Global Aptamers Market – Restraints

Stringent regulations related the use of aptamers and low awareness about these molecules in low- and middle-income countries are some of the factors that may challenge the growth of the market.

Global Aptamers Market - Regional Insights

On the basis of region, the global aptamers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global aptamers market, owing to presence of major key players and adoption of strategic collaborations. For instance, in March 2014, Siva Therapeutics, a biotechnology company initiated a research collaboration with SomaLogic, Inc., clinical diagnostic company  to determine the ability of SomaLogic’s SOMAmer (Slow-off Rate Modified Aptamer) reagents to actively target gold nanorods to solid tumors. This is expected to create more applications of aptamers in the near future.

Asia Pacific is the fastest growing region in the global aptamers market owing to increasing research and development in the field of aptamers. For instance, in 2015, scientists from the National Institute of Pharmaceutical Research, Mohali India, described the molecular mechanism of RNA aptamers which specifically targets drug resistant and metastatic cancer cells. The NIPER researchers selected the RNA aptamer through Cell-SELEX process.

Global Aptamers Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027

Aptamers  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2020)

Global Aptamers Market - Competitive Landscape

Key players operating in the global aptamers market include Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, SomaLogic, Inc., NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies and Vivonics Inc.

Aptamers are revolutionizing the healthcare industry by providing the affinity towards a desired target with high selectivity and specificity. This has led research scientists to gain interest in the field of aptamers with increasing support from public-private organizations. Companies such as Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, and SomaLogic, Inc. are collaborating with each other or independent research organizations and institutes to speed-up the research activities for the treatment of a number of diseases in order to decrease the time to market (TTM).

Market Dynamics

Aptamers offer significant advantages in comparison with protein therapeutics in terms of synthetic accessibility, size, and modification by medicinal chemistry which would aid the development of effective therapies. Continuous investments and development of novel aptamers by market players is expected to propel the market growth over the forecast period. Ophthotech is developing novel therapeutics, Fovista and Zimura (an aptamers), to treat eye diseases. Furthermore, advancements in Systemic Evolution of Ligands by Exponential Enrichment (SELEX) process to extract high-quality aptamers for a more diverse range of applications and government support in developed regions are projected to fuel utilization of these products, leading to market growth.

Key features of the study:

  • This report provides in-depth analysis of the global aptamers market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period, 2019-2027, considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global aptamers market based on the following parameters: company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study include Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, SomaLogic, Inc., NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies and Vivonics Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global aptamers market report caters to various stakeholders in this industry, which include investors, product manufacturers, distributors, and suppliers for global aptamers market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Aptamers Market, by Type:
    • Nucleic Acid Aptamers
      • DNA-Based Aptamers
      • RNA-Based Aptamers
      • XNA-Based Aptamers
    • Peptide Aptamers
  • Global Aptamers Market, by Application:
    • Diagnostics
    • Therapeutics
    • Research and Development
  • Global Aptamers Market, by End User:
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutions
    • Contract Research Organization
  • Global Aptamers Market, by Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Type:
        • Nucleic Acid Aptamers
          • DNA-Based Aptamers
          • RNA-Based Aptamers
          • XNA-Based Aptamers
        • Peptide Aptamers
      • By Application:
        • Diagnostics
        • Therapeutics
        • Research and Development
      • By End User:
        • Biotechnology and Pharmaceutical Companies
        • Academic and Research Institutions
        • Contract Research Organization
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Type:
        • Nucleic Acid Aptamers
          • DNA-Based Aptamers
          • RNA-Based Aptamers
          • XNA-Based Aptamers
        • Peptide Aptamers
      • By Application:
        • Diagnostics
        • Therapeutics
        • Research and Development
      • By End User:
        • Biotechnology and Pharmaceutical Companies
        • Academic and Research Institutions
        • Contract Research Organization
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Type:
        • Nucleic Acid Aptamers
          • DNA-Based Aptamers
          • RNA-Based Aptamers
          • XNA-Based Aptamers
        • Peptide Aptamers
      • By Application:
        • Diagnostics
        • Therapeutics
        • Research and Development
      • By End User:
        • Biotechnology and Pharmaceutical Companies
        • Academic and Research Institutions
        • Contract Research Organization
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Type:
        • Nucleic Acid Aptamers
          • DNA-Based Aptamers
          • RNA-Based Aptamers
          • XNA-Based Aptamers
        • Peptide Aptamers
      • By Application:
        • Diagnostics
        • Therapeutics
        • Research and Development
      • By End User:
        • Biotechnology and Pharmaceutical Companies
        • Academic and Research Institutions
        • Contract Research Organization
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Type:
        • Nucleic Acid Aptamers
          • DNA-Based Aptamers
          • RNA-Based Aptamers
          • XNA-Based Aptamers
        • Peptide Aptamers
      • By Application:
        • Diagnostics
        • Therapeutics
        • Research and Development
      • By End User:
        • Biotechnology and Pharmaceutical Companies
        • Academic and Research Institutions
        • Contract Research Organization
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Type:
        • Nucleic Acid Aptamers
          • DNA-Based Aptamers
          • RNA-Based Aptamers
          • XNA-Based Aptamers
        • Peptide Aptamers
      • By Application:
        • Diagnostics
        • Therapeutics
        • Research and Development
      • By End User:
        • Biotechnology and Pharmaceutical Companies
        • Academic and Research Institutions
        • Contract Research Organization
  • Company Profiles
    • Ophthotech Corporation
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Aptamer Sciences, Inc.
    • Novartis AG
    • SomaLogic, Inc.
    • NeoNeuro SAS
    • Aptagen, LLC
    • Aptus Biotech S.L.
    • AM Biotechnologies, LLC
    • Base Pair Biotechnologies
    • Vivonics Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type 
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
  4. Global Aptamers Market, By Type, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Nucleic Acid Aptamers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
        • DNA-Based Aptamers
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
        • RNA-Based Aptamers
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
        • XNA-Based Aptamers
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Peptide Aptamers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  5. Global Aptamers Market, By Application, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
    • Therapeutics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
    • Research and Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027 , (US$ Million)
  6. Global Aptamers Market, By End User, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Biotechnology and Pharmaceutical Companies
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Academic and Research Institutions
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Contract Research Organization
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Aptamers Market, By Region, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Type, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Type, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027 , (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Type , 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027 , (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027 , (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Company Profiles
      • Ophthotech Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Aptamer Sciences, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • SomaLogic, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • NeoNeuro SAS
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Aptagen, LLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Aptus Biotech S.L.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AM Biotechnologies, LLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Base Pair Biotechnologies
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Vivonics Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology         
    • About Us and Sales Contact

*Browse 35 market data tables and 32 figures on "Aptamers Market” - Global forecast to 2027

Frequently Asked Questions

The global aptamers market is estimated to surpass US$ 14,118.56 Million by 2027.
Major players operating in the global aptamers market market include Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, SomaLogic, Inc., NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies, and Vivonics Inc.
Among type, nucleic acid aptamers segment is expected to account for a major revenue share by 2027.
Growing incidence of life-threatening diseases such as cancer has driven many companies to introduce new detection assays based on aptamers therapy and this is one of the major factors that is expected to propel growth of the market over the forecast period.
The global aptamers market is estimated to exhibit a CAGR of 18.5% over the forecast period.
Among regions, North America is expected to hold dominant position in the market over the forecast period.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner